We hereby submit Audited Financial Results for Q4 and FY2026
YATHARTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Yatharth Hospital reported strong audited results for FY2026 with standalone revenue of ₹5,919 million (up 30% YoY) and consolidated revenue of ₹12,072 million (up 36% YoY). Standalone PAT grew 9% to ₹954 million while consolidated PAT grew 30% to ₹1,703 million. EPS improved to ₹18.20 per share on consolidated basis. The company has expanded its bed capacity significantly — a new 300-bed hospital in Delhi started in July 2025, a 400-bed hospital in Faridabad in September 2025, and a 150-bed hospital in Agra in February 2026. Finance costs increased sharply (standalone: ₹6.16M to ₹57.31M) reflecting higher debt to fund expansion. Auditors MSKA & Associates issued an unmodified opinion on both standalone and consolidated results.
Strong top-line growth of 30-36% YoY reflects successful hospital expansion. PAT growth of 30% on consolidated basis is solid. Rising finance costs and increased borrowings indicate leverage being used for growth — investors should monitor debt levels and integration of new hospitals.